Bisphenol F induced hyperglycemia via activation of oxidative stress-responsive miR-200 family in the pancreas

Novel insights into the causal relationship between endocrine-disrupting chemicals and breast cancer mediated by circulating metabolites

The relationship between endocrine-disrupting chemicals (EDCs) and breast cancer has not been extensively investigated. Although EDCs can disrupt human endocrine system, the underlying mechanism of EDCs on breast cancer requires further exploration. This study aimed to investigate the causal relationship between EDCs and breast cancer through Mendelian randomization (MR) and Generalised Summary-data-based Mendelian Randomization (GSMR) approach. Our results demonstrated that Bisphenol F was associated with increased risk of breast cancer [odds ratio (OR) = 1.018 (95 % CI 1.004-1.031), P = 0.010)]. Mono-(2-ethyl-5-carboxypentyl) phthalate (MECPP) was associated with lower breast cancer risk (OR = 0.894, 95 %CI = 0.819-0.975, P = 0.012). In addition, we identified 4 EDCs (bisphenol F, MECPP, Mono-ethyl phthalate, and Methyl paraben) significantly associated with ER + breast cancer. Furthermore, 3-bromo-5-chloro-2,6-dihydroxybenzoic acid mediated 10.9 % of the influence of MECPP on breast cancer. In addition, enrichment analysis was used to identify the pathways related to EDCs. MR-Phenome Wide Association Study (PheWAS) analysis was used to explore potential treatable diseases and adverse outcomes of EDCs. These findings shed light on the potential impact of EDCs exposure on breast cancer, which offer novel perspectives for future mechanistic and clinical research of EDCs and breast cancer.

Impact of fluoride exposure on reproductive health: Insights into molecular mechanisms and health implications

While the benefits of fluoride in preventing dental caries are well-established, concerns about its potential toxicity at high intake levels are rising. This review investigates the link between chronic fluoride exposure and reproductive health outcomes at the molecular level, focusing on population growth and child sex ratios in the fluorosis-affected and non-fluorosis regions. The exploration of the detrimental effects of fluoride on both male and female reproductive systems is necessary. In males, hormonal variations, alterations in spermatogenesis, capacitation, and sperm motility using molecular markers, epigenetic, transcriptomic, and proteomic data. For females, hormonal imbalances, disruptions in oocyte formation, teratogenicity (congenital disabilities), and compromised infant development due to maternal fluorosis using similar approaches. Furthermore, we explored drugs that address affected pathways, the potential benefits of vitamins and natural remedies, and lifestyle modifications to minimise adverse effects. The impact of various molecular pathways like apoptosis, autophagy, DNA damage, hormonal imbalance, inflammatory response, mitochondrial dynamics, and cell signalling pathways has been linked to reproductive toxicity induced by chronic and specific doses of fluoride. Analysing existing research and exploring potential therapeutic avenues contributes to the development of strategies to safeguard reproductive well-being in populations exposed to high fluoride levels.

Multi-miRNAs-Mediated Hepatic Lepr Axis Suppression: A Pparg-Dicer1 Pathway-Driven Mechanism in Spermatogenesis for the Intergenerational Transmission of Paternal Metabolic Syndrome

Bisphenol A (BPA) is an "environmental obesogen" and this study aims to investigate the intergenerational impacts of BPA-induced metabolic syndrome (MetS), specifically focusing on unraveling mechanisms. Exposure to BPA induces metabolic disorders in the paternal mice, which are then transmitted to offspring, leading to late-onset MetS. Mechanistically, BPA upregulates Srebf1, which in turn promotes the Pparg-dependent transcription of Dicer1 in spermatocytes, increasing the levels of multiple sperm microRNAs (miRNAs). Several of these miRNAs are highly expressed in a synchronized manner in liver of the offspring. miR149-5p, miR150-5p, and miR700-5p target a specific region in the Lepr 3'UTR, termed "SMITE" ("Several MiRNAs Targeting Elements"), to negatively regulate Lepr. These inherited anti-Lepr miRNAs, also referred to inherited anti-Lepr miRNAs (IAL-miRs), modulate hepatic steatosis, and insulin signaling through the Lepr regulatory Igfbp2, Egfr, and Ampk. Furthermore, IAL-miRs inhibit Ccnd1 not only via binding to "SMITE" but also via Lepr-Igfbp2 axis, which contribute to hepatocyte senescence. These pathological processes interact in a self-reinforcing cycle, worsening MetS in the paternal BPA-exposed offspring. The findings reveal mechanism wherein lipid metabolism reprogramming in spermatocytes-induced perturbations of sperm miRNAs, triggered by BPA, leads to intergenerational inheritance of paternal MetS through suppression of the hepatic Lepr axis in the offspring.

Emerging regulatory roles of noncoding RNAs induced by bisphenol a (BPA) and its alternatives in human diseases

Bisphenols (BPs), including BPA, BPF, BPS, and BPAF, are synthetic phenolic organic compounds and endocrine-disrupting chemicals. These organics have been broadly utilized to produce epoxy resins, polycarbonate plastics, and other products. Mounting evidence has shown that BPs, especially BPA, may enter into the human body and participate in the development of human diseases mediated by nuclear hormone receptors. Moreover, BPA may negatively affect human health at the epigenetic level through processes such as DNA methylation and histone acetylation. Recent studies have demonstrated that, as part of epigenetics, noncoding RNAs (ncRNAs), including microRNAs (miRNAs), long noncoding RNAs (lncRNAs), circular RNAs (circRNAs), and small nucleolar RNAs (snoRNAs), have vital impacts on BP-related diseases, such as reproductive system diseases, nervous system diseases, digestive system diseases, endocrine system diseases, and other diseases. Moreover, based on the bioinformatic analysis, changes in ncRNAs may be relevant to normal activities and functions and BP-induced diseases. Thus, we conducted a meta-analysis to identify more promising ncRNAs as biomarkers and therapeutic targets for BP exposure and relevant human diseases. In this review, we summarize the regulatory functions of ncRNAs induced by BPs in human diseases and latent molecular mechanisms, as well as identify prospective biomarkers and therapeutic targets for BP exposure and upper diseases.

The role of noncoding RNAs in beta cell biology and tissue engineering

The loss or dysfunction of pancreatic β-cells, which are responsible for insulin secretion, constitutes the foundation of all forms of diabetes, a widely prevalent disease worldwide. The replacement of damaged β-cells with regenerated or transplanted cells derived from stem cells is a promising therapeutic strategy. However, inducing the differentiation of stem cells into fully functional glucose-responsive β-cells in vitro has proven to be challenging. Noncoding RNAs (ncRNAs) have emerged as critical regulatory factors governing the differentiation, identity, and function of β-cells. Furthermore, engineered hydrogel systems, biomaterials, and organ-like structures possess engineering characteristics that can provide a three-dimensional (3D) microenvironment that supports stem cell differentiation. This review summarizes the roles and contributions of ncRNAs in maintaining the differentiation, identity, and function of β-cells. And it focuses on regulating the levels of ncRNAs in stem cells to activate β-cell genetic programs for generating alternative β-cells and discusses how to manipulate ncRNA expression by combining hydrogel systems and other tissue engineering materials. Elucidating the patterns of ncRNA-mediated regulation in β-cell biology and utilizing this knowledge to control stem cell differentiation may offer promising therapeutic strategies for generating functional insulin-producing cells in diabetes cell replacement therapy and tissue engineering.

Coreopsis tinctoria improves energy metabolism in obese hyperglycemic mice

Coreopsis tinctoria (CT) improves energy metabolism. However, the role of CT in alleviating obesity-induced hyperglycemia by targeting the liver remains unknown. Therefore, this article aims to explore the mechanism by which CT improves energy metabolism and resists hyperglycemia. The water and ethanol extracts of CT were administered to high-fat diet-induced (HFD) obese C57BL/6J mice at a dose of 4 g/kg.bw (low-dose water extract, WL; low-dose ethanol extract, EL) or 10 g/kg.bw (high-dose water extract, WH; high-dose ethanol extract, EH). Mice that consumed a maintenance diet (LFD) were included as blank controls. Network pharmacology, liquid chromatography-mass spectrometry (LC-MS), L02 cell cultivation, and liver transcriptomics were used to examine the mechanism and functional components of CT against obesity-induced hyperglycemia. The results indicated that WL significantly (p < 0.05) alleviated glucose intolerance and insulin resistance in obesity-induced hyperglycemia. Kaempferol is the main active compound of CT, which demonstrated significant (p < 0.05) anti-hyperglycemic effects in obese mice and L02 cells. Finally, kaempferol significantly (p < 0.05; fold change >1.2) shifted the genes involved in carbon metabolism, glycolysis/gluconeogenesis, and the mitogen-activated protein kinase (MAPK) pathways toward the trend of LFD, indicating that it exerts an anti-hyperglycemic effect through these molecular mechanisms. Overall, oral intake of CT lowers blood glucose and improves insulin sensitivity in mice with obesity-induced hyperglycemia. Kaempferol is the primary functional component of CT.